Business Description
Health Italia SpA
ISIN : IT0005585861
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.29 | |||||
Debt-to-EBITDA | 1.96 | |||||
Interest Coverage | 7.85 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.98 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.4 | |||||
3-Year EBITDA Growth Rate | 12 | |||||
3-Year EPS without NRI Growth Rate | -1 | |||||
3-Year FCF Growth Rate | 271.1 | |||||
3-Year Book Growth Rate | 10.6 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.5 | |||||
9-Day RSI | 47.62 | |||||
14-Day RSI | 48.33 | |||||
6-1 Month Momentum % | -15.97 | |||||
12-1 Month Momentum % | -28.61 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.61 | |||||
Quick Ratio | 2.61 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 28.64 | |||||
Days Sales Outstanding | 299.66 | |||||
Days Payable | 208.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 26.67 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 35.81 | |||||
Operating Margin % | 16.02 | |||||
Net Margin % | 4.57 | |||||
FCF Margin % | 5.93 | |||||
ROE % | 4.9 | |||||
ROA % | 2.38 | |||||
ROIC % | 6.02 | |||||
ROC (Joel Greenblatt) % | 12.73 | |||||
ROCE % | 9.22 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.06 | |||||
PE Ratio without NRI | 7.82 | |||||
Price-to-Owner-Earnings | 26.29 | |||||
PEG Ratio | 0.87 | |||||
PS Ratio | 0.68 | |||||
PB Ratio | 0.69 | |||||
Price-to-Tangible-Book | 0.76 | |||||
Price-to-Free-Cash-Flow | 11.6 | |||||
Price-to-Operating-Cash-Flow | 11.6 | |||||
EV-to-EBIT | 8.44 | |||||
EV-to-EBITDA | 6.43 | |||||
EV-to-Revenue | 0.94 | |||||
EV-to-FCF | 16.06 | |||||
Price-to-Projected-FCF | 1.47 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.87 | |||||
Price-to-Graham-Number | 0.51 | |||||
Price-to-Net-Current-Asset-Value | 1.14 | |||||
Earnings Yield (Greenblatt) % | 11.85 | |||||
FCF Yield % | 8.63 | |||||
Forward Rate of Return (Yacktman) % | 13.62 |